XML 22 R11.htm IDEA: XBRL DOCUMENT v3.25.3

INVENTORY

9 Months Ended

Sep. 30, 2025

Inventory Disclosure [Abstract]

INVENTORY

NOTE 5 – INVENTORY

Inventory consists of the following components:

SCHEDULE OF INVENTORY

		September 30, 2025				December 31, 2025
Raw materials		$	1,702			$	391
Finished goods			541				1,800
Total inventory		$	2,243			$	2,191

Inventory write-down charged to the cost of sales amounted to $119 for the nine months ended September 30, 2025, respectively, to reduce inventory to its net realizable value and for any excess or obsolete inventory.

The Company identified certain inaccuracies in its 510(k) application for the PainShield MD Plus product and on August 19, 2025 submitted a request to the U.S. Food and Drug Administration (FDA) to withdraw the clearance. While the Company is unaware of any safety issues related to the PainShield MD Plus product, it has decided to halt future sales. An appropriate inventory allowance was recorded for the impact of halt in sales in the amount of $119.

X

- References

No definition available.

+ Details

Name:	us-gaap_InventoryDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 330
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/330/tableOfContent

+ Details

Name:	us-gaap_InventoryDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration